Biotech · Private company
Calico Life Sciences LLC
Track this companyFree. Adds Calico Life Sciences LLC to your Dealase workspace and tells you when its record changes.
Clinical trials113 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- ABBV-CLS-628Phase 2 · Autosomal Dominant Polycystic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- FosigotifatorPhase 2 · Vanishing White Matter DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- [14C] ABBV-CLS-7262Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- ABBV-CLS-484Phase 1 · Advanced Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
- ABBV-CLS-7262Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin 400mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Programmed Cell Death-1 (PD-1) InhibitorPhase 1 · Advanced Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
- Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)Phase 1 · Advanced Solid Tumor CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)PHASE2 · RECRUITING · started Jun 9, 2025ClinicalTrials.gov NCT06902558 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Nov 11, 2024ClinicalTrials.gov NCT06698926 · fetched Nov 12, 2026
- Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose AdministrationPHASE1 · COMPLETED · started May 21, 2024ClinicalTrials.gov NCT06425003 · fetched Nov 12, 2026
- A Thorough QT Study of ABBV-CLS-7262 in Healthy SubjectsPHASE1 · COMPLETED · started Mar 14, 2024ClinicalTrials.gov NCT06310876 · fetched Nov 12, 2026
- A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262PHASE1 · COMPLETED · started Dec 19, 2023ClinicalTrials.gov NCT06145607 · fetched Nov 12, 2026
- A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy SubjectsPHASE1 · COMPLETED · started Mar 24, 2023ClinicalTrials.gov NCT05763459 · fetched Nov 12, 2026
- HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262PHASE2_PHASE3 · COMPLETED · started Mar 23, 2023ClinicalTrials.gov NCT05740813 · fetched Nov 12, 2026
- An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter DiseasePHASE1_PHASE2 · RECRUITING · started Mar 13, 2023ClinicalTrials.gov NCT05757141 · fetched Nov 12, 2026
- A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral SclerosisPHASE1 · TERMINATED · started Sep 22, 2021ClinicalTrials.gov NCT04948645 · fetched Nov 12, 2026
- Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsPHASE1 · RECRUITING · started Mar 9, 2021ClinicalTrials.gov NCT04777994 · fetched Nov 12, 2026
- First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic TumorsPHASE1 · COMPLETED · started Jun 3, 2020ClinicalTrials.gov NCT04417465 · fetched Nov 12, 2026